Optimizing Antiplatelet Therapy in Cardiogenic SHOCK-Optimal Antiplatelet Strategies in High-Risk Patients?

Optimal Antiplatelet Strategies in High-Risk Patients?

Video Transcription

Video Summary

The talk discusses optimal antiplatelet strategies for high-risk patients, focusing on current practices and future developments. Presently, the aim is rapid onset and reversible antiplatelet therapy to manage reperfusion, minimize bleeding, and address complications like thrombocytopenia. Cangrelor is highlighted for its effectiveness, but challenges remain, especially in patients on mechanical support. Recent studies show no significant differences in bleeding and thrombotic events across various antiplatelet combinations. Future prospects include new drugs like ticagrelor reversal agent and subcutaneous antiplatelets, which may enhance treatment options in this complex patient group.

Asset Subtitle

Greg W. Serrao, MD, FSCAI

Keywords

antiplatelet strategies

high-risk patients

cangrelor

ticagrelor reversal

subcutaneous antiplatelets